What are alternatives to cyclopentolate eye drops?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Atropine eye drops are a suitable alternative to cyclopentolate eye drops.

Alternatives to Cyclopentolate Eye Drops

  • Atropine: Atropine is a commonly used alternative to cyclopentolate, with studies showing its efficacy in slowing the progression of myopia 1. Atropine 0.01% has been found to have minimal side effects and is effective in controlling myopia progression.
  • Tropicamide: Tropicamide 1% has been used in combination with phenylephrine hydrochloride 2.5% to produce adequate dilation and cycloplegia, although it was found to have no significant difference in the progression of myopia compared to controls in one study 1.
  • Pirenzepine hydrochloride: Pirenzepine hydrochloride 2% ophthalmic gel has been evaluated in two multicenter, double-masked, placebo-controlled parallel studies and was found to be effective and relatively safe in slowing myopia progression over a 1-year treatment period 1.

Important Considerations

  • The choice of alternative to cyclopentolate eye drops depends on the individual patient's needs and the specific condition being treated.
  • Atropine is a commonly used alternative, but it can have side effects such as photosensitivity, conjunctival irritation, and systemic effects like dryness of the mouth and skin, fever, delirium, and tachycardia 1.
  • The use of topical anesthetic prior to the cycloplegic agent can reduce stinging and promote penetration of subsequent eyedrops 1.

From the Research

Alternatives to Cyclopentolate Eye Drops

Alternatives to cyclopentolate eye drops include:

  • Tropicamide: a viable substitute for cyclopentolate due to its rapid onset of action 2, 3
  • Atropine: has the strongest cycloplegic effect and is recommended for cases of large accommodative esotropia, but has undesired side effects and risks 4
  • Phenylephrine: can be used in combination with tropicamide or cyclopentolate for mydriasis 5
  • Cycolmydril: can be used under six months old as recommended by the AAO 4

Comparison of Alternatives

Studies have compared the efficacy of cyclopentolate and tropicamide in controlling accommodation during refraction:

  • A meta-analysis found that the cycloplegic effect of cyclopentolate was stronger than tropicamide, but the difference was only statistically significant in children, hyperopic patients, and with retinoscopy 2
  • A randomized clinical trial found that tropicamide 1% and cyclopentolate 1% had similar effects on cycloplegic refraction in pediatric patients with brown irides 3

Stability of Alternatives

The stability of extemporaneously prepared ophthalmic solutions containing combinations of phenylephrine, tropicamide, and cyclopentolate has been evaluated:

  • A stability study found that adult and pediatric ophthalmic formulations containing combinations of phenylephrine, tropicamide, and cyclopentolate were stable physically and chemically for up to 60 days when stored at refrigeration temperatures (2-8 °C) 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Stability of extemporaneously prepared ophthalmic solutions for mydriasis.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.